Published in Nat Rev Microbiol on December 11, 2006
Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov (2010) 2.69
Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest (2011) 2.66
C-type lectin receptors orchestrate antifungal immunity. Nat Immunol (2012) 1.89
An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov (2010) 1.78
Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One (2009) 1.59
Population genomic sequencing of Coccidioides fungi reveals recent hybridization and transposon control. Genome Res (2010) 1.46
Adaptive immunity to fungi. Annu Rev Immunol (2012) 1.41
Fungal infections in primary immunodeficiencies. Eur J Pediatr (2007) 1.37
Dendritic cells in antifungal immunity and vaccine design. Cell Host Microbe (2012) 1.35
A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis. Infect Immun (2009) 1.23
Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci U S A (2008) 1.22
Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes. Immunity (2012) 1.17
The human mycobiome in health and disease. Genome Med (2013) 1.16
C-type lectin receptors differentially induce th17 cells and vaccine immunity to the endemic mycosis of North America. J Immunol (2014) 1.04
The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies. Vaccine (2009) 1.00
Recent progress in vaccines against fungal diseases. Curr Opin Microbiol (2012) 1.00
Development of vaccines for Candida albicans: fighting a skilled transformer. Nat Rev Microbiol (2013) 0.98
Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol (2011) 0.98
Protective antifungal memory CD8(+) T cells are maintained in the absence of CD4(+) T cell help and cognate antigen in mice. J Clin Invest (2012) 0.96
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges. Front Microbiol (2012) 0.96
Histoplasma capsulatum at the host-pathogen interface. Microbes Infect (2008) 0.94
Anticandidal immunity and vaginitis: novel opportunities for immune intervention. Infect Immun (2007) 0.93
Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis. Clin Vaccine Immunol (2011) 0.92
FungalRV: adhesin prediction and immunoinformatics portal for human fungal pathogens. BMC Genomics (2011) 0.92
Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis. Br J Pharmacol (2010) 0.91
Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis. Infect Immun (2007) 0.91
Fungal cell wall vaccines: an update. J Med Microbiol (2012) 0.91
Host defense pathways against fungi: the basis for vaccines and immunotherapy. Front Microbiol (2012) 0.88
Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus. PLoS One (2011) 0.88
Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan. Clin Vaccine Immunol (2008) 0.88
Extracellular proteome of Aspergillus terreus grown on different carbon sources. Curr Genet (2010) 0.88
Prospects for development of a vaccine to prevent and control vaginal candidiasis. Curr Infect Dis Rep (2011) 0.87
Vaccines in the treatment of invasive candidiasis. Virulence (2015) 0.86
Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis. PLoS One (2012) 0.86
Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models. Front Microbiol (2012) 0.86
Progress Toward a Human Vaccine Against Coccidioidomycosis. Curr Fungal Infect Rep (2012) 0.84
A Candida albicans mannoprotein deprived of its mannan moiety is efficiently taken up and processed by human dendritic cells and induces T-cell activation without stimulating proinflammatory cytokine production. Infect Immun (2008) 0.84
Vaccines to prevent systemic mycoses: holy grails meet translational realities. J Infect Dis (2008) 0.83
Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice. Hum Vaccin Immunother (2014) 0.82
Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infection. J Infect Dis (2013) 0.81
Studies of Immune Responses in Candida vaginitis. Pathogens (2015) 0.81
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism. Semin Immunopathol (2014) 0.81
Synthesis and immunological studies of linear oligosaccharides of β-glucan as antigens for antifungal vaccine development. Bioconjug Chem (2015) 0.80
Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection. Adv Healthc Mater (2016) 0.78
Fungal vaccines and immunotherapeutics. Cold Spring Harb Perspect Med (2014) 0.77
The antifungal pipeline: a reality check. Nat Rev Drug Discov (2017) 0.77
Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis. J Immunol (2015) 0.76
Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat Rev Immunol (2017) 0.75
New insights on the development of fungal vaccines: from immunity to recent challenges. Mem Inst Oswaldo Cruz (2015) 0.75
MyD88 Shapes Vaccine Immunity by Extrinsically Regulating Survival of CD4+ T Cells during the Contraction Phase. PLoS Pathog (2016) 0.75
Editorial: Vaccines, Immunotherapy and New Antifungal Therapy against Fungi: Updates in the New Frontier. Front Microbiol (2017) 0.75
Human yeast-specific CD8 T lymphocytes show a nonclassical effector molecule profile. Med Microbiol Immunol (2011) 0.75
Direct gene transfer into mouse muscle in vivo. Science (1990) 10.39
Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science (2003) 10.22
Defective CD8 T cell memory following acute infection without CD4 T cell help. Science (2003) 9.67
TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol (2004) 8.06
Immunity to fungal infections. Nat Rev Immunol (2004) 3.58
Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun (2000) 3.42
A third type of murine T-cell receptor gene. Nature (1984) 3.24
Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol (2004) 3.13
Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol (2006) 3.04
Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature (2002) 3.01
Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog (2005) 3.01
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis (1992) 2.98
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
Does the microbiota regulate immune responses outside the gut? Trends Microbiol (2004) 2.69
Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J Exp Med (1991) 2.64
Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun (1987) 2.63
Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun (1991) 2.46
Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol (2006) 2.43
Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics (2001) 2.40
A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med (2005) 2.35
DNA vaccines: progress and challenges. J Immunol (2005) 2.34
Antibody response that protects against disseminated candidiasis. Infect Immun (1995) 2.31
Antibody immunity and invasive fungal infections. Infect Immun (1995) 2.31
The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol (1994) 2.20
Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol (2000) 2.14
Fungal beta-glucans and mammalian immunity. Immunity (2003) 2.13
Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol (1996) 2.12
Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med (1995) 2.11
Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med (1997) 2.09
Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem (2000) 2.08
Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun (2004) 2.04
IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol (1995) 1.94
Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun (2005) 1.85
CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity (2002) 1.83
Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol (2002) 1.83
Coccidioidomycosis: host response and vaccine development. Clin Microbiol Rev (2004) 1.82
More is not necessarily better: prozone-like effects in passive immunization with IgG. J Immunol (2003) 1.81
CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. J Clin Invest (2001) 1.76
Immunological characteristics associated with the protective efficacy of antibodies to ricin. J Immunol (2004) 1.76
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat Biotechnol (1997) 1.75
Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol (1998) 1.75
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med (1993) 1.73
CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J Immunol (2002) 1.73
Passive immunization of mice against Candida albicans. Sabouraudia (1968) 1.73
Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J Immunol (1997) 1.68
Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun (1997) 1.68
Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J Exp Med (1999) 1.67
Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis. J Infect Dis (2006) 1.64
Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun (1997) 1.63
Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J Immunol (1978) 1.61
A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect Immun (1998) 1.60
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest (2003) 1.60
Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59
Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med (2003) 1.58
Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J Immunol (2002) 1.56
Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect Immun (1989) 1.56
Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol (1999) 1.54
Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology (1991) 1.49
T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol (2000) 1.48
A vaccine against coccidioidomycosis is justified and attainable. Med Mycol (2004) 1.48
Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J Immunol (2001) 1.48
Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med (2001) 1.47
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood (2003) 1.45
A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol (2006) 1.42
Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. Structure-antigenicity relationship between the cell wall mannans of Candida albicans and Candida parapsilosis. J Biol Chem (1995) 1.41
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect Immun (2003) 1.37
Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model. Vaccine (1996) 1.37
CD4+ T cell-independent DNA vaccination against opportunistic infections. J Clin Invest (2005) 1.33
In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. J Clin Invest (1986) 1.31
Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis (2005) 1.31
Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur J Immunol (2003) 1.30
Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect (2002) 1.30
Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun (2003) 1.29
Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. J Immunol (1999) 1.28
Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance. J Clin Invest (2000) 1.27
Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect Immun (1996) 1.27
Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev (1998) 1.26
Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J Infect Dis (1997) 1.23
Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol (2002) 1.22
Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A. Infect Immun (1989) 1.22
Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J Infect Dis (1999) 1.21
Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group. Am Rev Respir Dis (1993) 1.21
Fab fragments from a monoclonal antibody against a germ tube mannoprotein block the yeast-to-mycelium transition in Candida albicans. Infect Immun (1990) 1.20
Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. J Infect Dis (1995) 1.20
DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from paracoccidioides brasiliensis. Vaccine (2000) 1.18
A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol (2005) 1.17
Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection. J Infect Dis (1999) 1.17
Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators. Curr Med Chem (2004) 1.16
Role of CD8+ T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J Immunol (1994) 1.16
Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans. Curr Mol Med (2005) 1.14
Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem (2003) 1.13
Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine (1998) 1.12
Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J Lab Clin Med (1993) 1.12
Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines. Sabouraudia (1971) 1.11
Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J Immunol (2003) 1.10
T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice. J Immunol (2004) 1.10
DNA vaccines. N Engl J Med (1996) 1.09
A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis. Infect Immun (2003) 1.08
Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein. Vaccine (2006) 1.07
Relative abundance of oligosaccharides in Candida species as determined by fluorophore-assisted carbohydrate electrophoresis. J Clin Microbiol (2000) 1.07
Global control of dimorphism and virulence in fungi. Science (2006) 3.50
Granulocyte macrophage-colony stimulating factor induced Zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival. Immunity (2013) 1.77
CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection. J Immunol (2010) 1.62
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest (2003) 1.60
Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med (2003) 1.58
Immune defects in 28-kDa proteasome activator gamma-deficient mice. J Immunol (2004) 1.46
Adaptive immunity to fungi. Annu Rev Immunol (2012) 1.41
Dendritic cells in antifungal immunity and vaccine design. Cell Host Microbe (2012) 1.35
Agrobacterium tumefaciens integrates transfer DNA into single chromosomal sites of dimorphic fungi and yields homokaryotic progeny from multinucleate yeast. Eukaryot Cell (2002) 1.29
T cell receptor cross-reactivity between similar foreign and self peptides influences naive cell population size and autoimmunity. Immunity (2015) 1.29
The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J Immunol (2009) 1.27
PCR assay for identification of histoplasma capsulatum based on the nucleotide sequence of the M antigen. J Clin Microbiol (2003) 1.24
Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol (2002) 1.22
Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes. Immunity (2012) 1.17
Exploiting type 3 complement receptor for TNF-alpha suppression, immune evasion, and progressive pulmonary fungal infection. J Immunol (2004) 1.16
Fungal adaptation to the mammalian host: it is a new world, after all. Curr Opin Microbiol (2008) 1.15
Linking fungal morphogenesis with virulence. Cell Microbiol (2002) 1.15
Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem (2003) 1.13
Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi. Cell Host Microbe (2010) 1.13
Metallomic analysis of macrophages infected with Histoplasma capsulatum reveals a fundamental role for zinc in host defenses. J Infect Dis (2010) 1.12
Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum. J Clin Invest (2005) 1.06
A TCR transgenic mouse reactive with multiple systemic dimorphic fungi. J Immunol (2011) 1.03
Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17). Infect Immun (2011) 1.03
Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation. Mycopathologia (2002) 1.02
The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V beta 8.1/8.2+ T cells. J Immunol (2002) 1.02
BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms. J Immunol (2002) 1.01
Leukotrienes are potent adjuvant during fungal infection: effects on memory T cells. J Immunol (2008) 1.01
Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog (2012) 1.01
Regulation of immunoproteasome subunit expression in vivo following pathogenic fungal infection. J Immunol (2002) 1.00
IL-12 is required for induction but not maintenance of protective, memory responses to Blastomyces dermatitidis: implications for vaccine development in immune-deficient hosts. J Immunol (2005) 0.97
Genetic diversity in Blastomyces dermatitidis: implications for PCR detection in clinical and environmental samples. Med Mycol (2010) 0.95
Variation in Pseudonocardia antibiotic defence helps govern parasite-induced morbidity in Acromyrmex leaf-cutting ants. Environ Microbiol Rep (2009) 0.95
SREB, a GATA transcription factor that directs disparate fates in Blastomyces dermatitidis including morphogenesis and siderophore biosynthesis. PLoS Pathog (2010) 0.94
Identification and characterization of antifungal compounds using a Saccharomyces cerevisiae reporter bioassay. PLoS One (2012) 0.94
Immunotherapy for fungal infections. Clin Infect Dis (2006) 0.93
Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1. Clin Vaccine Immunol (2013) 0.93
Innate and adaptive determinants of host susceptibility to medically important fungi. Curr Opin Microbiol (2003) 0.92
Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis. J Immunol (2006) 0.92
Calcium binding by the essential virulence factor BAD-1 of Blastomyces dermatitidis. J Biol Chem (2005) 0.90
Vaccination with heat shock protein 60 induces a protective immune response against experimental Paracoccidioides brasiliensis pulmonary infection. Infect Immun (2008) 0.90
Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity. Med Mycol (2005) 0.90
V beta1+ J beta1.1+/V alpha2+ J alpha49+ CD4+ T cells mediate resistance against infection with Blastomyces dermatitidis. Infect Immun (2006) 0.89
Chitin elicits CCL2 from airway epithelial cells and induces CCR2-dependent innate allergic inflammation in the lung. J Immunol (2012) 0.89
Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum. Infect Immun (2003) 0.89
B cells and CD4-CD8- T cells are key regulators of the severity of reactivation histoplasmosis. J Immunol (2006) 0.88
The role of cytokines and chemokines in Histoplasma capsulatum infection. Cytokine (2011) 0.87
An aberrant thymus in CCR5-/- mice is coupled with an enhanced adaptive immune response in fungal infection. J Immunol (2011) 0.86
Insights into Fungal Morphogenesis and Immune Evasion: Fungal conidia, when situated in mammalian lungs, may switch from mold to pathogenic yeasts or spore-forming spherules. Microbe Wash DC (2008) 0.86
Heterologous expression, purification, and immunological reactivity of a recombinant HSP60 from Paracoccidioides brasiliensis. Clin Diagn Lab Immunol (2002) 0.85
Non-rural point source blastomycosis outbreak near a yard waste collection site. Clin Med Res (2010) 0.85
Selectivity and specificity of small molecule fluorescent dyes/probes used for the detection of Zn2+ and Ca2+ in cells. Metallomics (2014) 0.84
Identification of the mating-type (MAT) locus that controls sexual reproduction of Blastomyces dermatitidis. Eukaryot Cell (2012) 0.83
Blastomyces dermatitidis yeast cells inhibit nitric oxide production by alveolar macrophage inducible nitric oxide synthase. Infect Immun (2011) 0.83
Antigen-presenting dendritic cells rescue CD4-depleted CCR2-/- mice from lethal Histoplasma capsulatum infection. Infect Immun (2010) 0.83
Discordant influence of Blastomyces dermatitidis yeast-phase-specific gene BYS1 on morphogenesis and virulence. Infect Immun (2010) 0.82
Histoplasma capsulatum proteome response to decreased iron availability. Proteome Sci (2008) 0.81
Expression of hygromycin phosphotransferase alters virulence of Histoplasma capsulatum. Eukaryot Cell (2007) 0.81
Sequence elements necessary for transcriptional activation of BAD1 in the yeast phase of Blastomyces dermatitidis. Eukaryot Cell (2004) 0.81
CD28 is required for optimal induction, but not maintenance, of vaccine-induced immunity to Blastomyces dermatitidis. Infect Immun (2005) 0.81
Interleukin-1 receptor but not Toll-like receptor 2 is essential for MyD88-dependent Th17 immunity to Coccidioides infection. Infect Immun (2014) 0.81
Using new genetic tools to study the pathogenesis of Blastomyces dermatitidis. Trends Microbiol (2002) 0.81
Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infection. J Infect Dis (2013) 0.81
The catalases of Paracoccidioides brasiliensis are differentially regulated: protein activity and transcript analysis. Fungal Genet Biol (2008) 0.80
Detection and measurement of two-component systems that control dimorphism and virulence in fungi. Methods Enzymol (2007) 0.80
A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis (2013) 0.79
The antigenic and catalytically active formamidase of Paracoccidioides brasiliensis: protein characterization, cDNA and gene cloning, heterologous expression and functional analysis of the recombinant protein. Microbes Infect (2004) 0.79
A deficiency in gamma interferon or interleukin-10 modulates T-Cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum. Infect Immun (2005) 0.79
Analysis of non-adhesive pathogenic mechanisms of BAD1 on Blastomyces dermatitidis. Med Mycol (2006) 0.78
Isolation of Blastomyces dermatitidis yeast from lung tissue during murine infection for in vivo transcriptional profiling. Fungal Genet Biol (2013) 0.77
Characterization of a gene which encodes a mannosyltransferase homolog of Paracoccidioides brasiliensis. Microbes Infect (2002) 0.77
Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective response. J Infect Dis (2006) 0.77
Safety, tolerability, and immunogenicity of a recombinant, genetically engineered, live-attenuated vaccine against canine blastomycosis. Clin Vaccine Immunol (2011) 0.77
Fungal glycan interactions with epithelial cells in allergic airway disease. Curr Opin Microbiol (2013) 0.76
CCR5 deficiency mitigates the deleterious effects of tumor necrosis factor α antagonism in murine histoplasmosis. J Infect Dis (2012) 0.75
Structural-functional relationships of TNF-alpha antagonists: next steps. J Investig Dermatol Symp Proc (2007) 0.75
Aspergillus fumigatus Copper Export Machinery and Reactive Oxygen Intermediate Defense Counter Host Copper-Mediated Oxidative Antimicrobial Offense. Cell Rep (2017) 0.75